Fidelity Low Duration Bond ETF (FLDB)
Live price chart, market sentiment, and community perspectives for Fidelity Low Duration Bond ETF (NASDAQ: FLDB).
Live price chart, market sentiment, and community perspectives for Fidelity Low Duration Bond ETF (NASDAQ: FLDB).
Looking at the market sentiment for FLDB, the fund is clearly capturing attention as a robust cash-alternative sleeve. With portfolio assets sitting around $405.6M and an expense ratio of 0.20%, it offers an efficient vehicle for clients wanting to park capital safely without taking on major duration risk. The active management style allows the team to navigate asset allocation and yield-curve positioning effectively.
From a risk management perspective, FLDB's metrics stand out significantly. The 5-year equity beta is effectively 0.02, and the Sortino ratio reaches an impressive 7.36, which is dramatically above the typical ultrashort bond range of 1 to 3. This signals almost no meaningful downside volatility, making it a stellar defensive anchor during periods of broader macro uncertainty.
When analyzing the technical characteristics for our fixed-income positioning, I note that FLDB maintains a weighted average maturity of 1.10 years and a duration of 0.60 years. Its benchmark is the Bloomberg U.S. Treasury Bill 6-9 Months Index. The 30-day SEC yield of 4.06% provides a stable baseline return for conservative mandates, though analysts must note its lower relative return profile versus more aggressive credit peers.
On our trading desk, liquidity and turnover are key parameters. FLDB exhibits a turnover rate of 59% with 394 total holdings as of March 2026. This granular diversification across investment-grade debt securities ensures that single-issuer credit events have a heavily mitigated impact on the overall portfolio structure.
Evaluating the trade-offs of the fund's mandate, it's clear why Morningstar categorizes it under Ultrashort Bond with a Conservative risk score of 2. The category maximum drawdown of -1.4% over its tracked windows highlights exceptional resilience compared to the broader index's -4.2% drop, validating its core objective of high current income consistent with capital preservation.
Explore plasma cleansing, somatic organ swaps, and BCI.